The DOI matches its Crossref record; 181 of the 190 references it cites were found in a registry or an index.
Wnt signaling and cancer
Open accessAbstract
The regulation of cell growth and survival can be subverted by a variety of genetic defects that alter transcriptional programs normally responsible for controlling cell number. High throughput analysis of these gene expression patterns should ultimately lead to the identification of minimal expression profiles that will serve as common denominators in assigning a cancer to a given category. In the course of defining the common denominators, though, we should not be too surprised to find that cancers within a single category may nevertheless exhibit seemingly disparate genetic defects. The wnt pathway has already provided an outstanding example of this. We now know of three regulatory genes in this pathway that are mutated in primary human cancers and several others that promote experimental cancers in rodents (Fig. 1). In all of these cases the common denominator is the activation of gene transcription by -catenin. The resulting gene expression profile should provide us with a signature common to those cancers carrying defects in the wnt pathway. In this review, the wnt pathway will be covered from the perspective of cancer, with emphasis placed on molecular defects known to promote neoplastic transformation in humans and in animal models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Constitutive activation of this pathway is also implicated in cancer development in several other organs (140).”
From Adrenal incidentaloma (2020) · cites this paper as [140]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of c- MYC as a Target of the APC Pathway
He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · Science · doi:10.1126/science.281.5382.1509 · Cited by 4,566
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
Morin, P. J., Sparks, A. B., Kořínek, V., Barker, N., Clevers, H. C., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.275.5307.1787 · Cited by 4,000
β-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601
Functional interaction of β-catenin with the transcription factor LEF-1
Behrens, J., von Kries, J. P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R., & Birchmeier, W. (1996) · Nature · doi:10.1038/382638a0 · Cited by 2,912
Identification and characterization of the familial adenomatous polyposis coli gene
Groden, J. L., Thliveris, A. T., Samowitz, W. S., Carlson, M. L., Gelbert, L. M., Albertsen, H., Joslyn, G., Stevens, J., Spirio, L. N., Robertson, M. A., et al. (1991) · Cell · doi:10.1016/0092-8674(81)90021-0 · Cited by 2,794
Identification of FAP Locus Genes from Chromosome 5q21
Kinzler, K. W., Nilbert, M. C., Su, L.-K., Vogelstein, B., Bryan, T. M., Levy, D. B., Smith, K. J., Preisinger, A. C., Hedge, P., McKechnie, D., et al. (1991) · Science · doi:10.1126/science.1651562 · Cited by 2,331
The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D’Amico, M., Pestell, R., & Ben-Ze’ev, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5522 · Cited by 2,230
MECHANISMS OF WNT SIGNALING IN DEVELOPMENT
Wodarz, A., & Nusse, R. (1998) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.14.1.59 · Cited by 2,030
Nusse, R., & VARMUS, H. E. (1982) · Cell · doi:10.1016/0092-8674(82)90409-3 · Cited by 1,864
XTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos
Molenaar, M., van de Wetering, M., Oosterwegel, M., Peterson-Maduro, J., Godsave, S., Korinek, V., Roose, J., Destrée, O., & Clevers, H. (1996) · Cell · doi:10.1016/s0092-8674(00)80112-9 · Cited by 1,824
Research works printed but not linked: 1
- 10.1210/jc.85.1.286 · DOI
Cited by
Sorted by citations
Items 601–700 of 1,005
The Wnt/β-Catenin Signaling Pathway as a Target in Drug Discovery
Takahashi‐Yanaga, F., & Sasaguri, T. (2007) · Journal of Pharmacological Sciences · doi:10.1254/jphs.cr0070024 · Cited by 137
de Bont, J. M., Packer, R. J., Michiels, E. M. C., den Boer, M. L., & Pieters, R. (2008) · Neuro-Oncology · doi:10.1215/15228517-2008-059 · Cited by 133
Transcriptional Activation of Interleukin-8 by β-Catenin-Tcf4
Lévy, L., Neuveut, C., Renard, C.-A., Charneau, P., Branchereau, S., Gauthier, F., Nhieu, J. T. V., Cherqui, D., Petit-Bertron, A.-F., Mathieu-Mahul, D., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207418200 · Cited by 133
Wnt Inhibitory Factor 1 Decreases Tumorigenesis and Metastasis in Osteosarcoma
Rubin, E. M., Guo, Y., Tu, K., Xie, J., Zi, X., & Hoang, B. H. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0147 · Cited by 132
Association of Csk to VE‐cadherin and inhibition of cell proliferation
Baumeister, U., Funke, R., Ebnet, K., Vorschmitt, H., Koch, S., & Vestweber, D. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600647 · Cited by 132
Targeting Gsk-3: A Promising Approach For Cancer Therapy?
Ougolkov, A. V., & Billadeau, D. D. (2006) · Future Oncology · doi:10.2217/14796694.2.1.91 · Cited by 130
Identification of the LIM Protein FHL2 as a Coactivator of β-Catenin
Yu, W., Renard, C.-A., Labalette, C., Wu, Y., Lévy, L., Neuveut, C., Prieur, X., Flajolet, M., Prigent, S., & Buendia, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207216200 · Cited by 132
Fujimuro, M., & Hayward, S. D. (2003) · Journal of Virology · doi:10.1128/jvi.77.14.8019-8030.2003 · Cited by 131
Protein phosphatase 1 regulates assembly and function of the β‐catenin degradation complex
Luo, W., Peterson, A. G., Garcia, B. A., Coombs, G. S., Kofahl, B., Heinrich, R., Shabanowitz, J., Hunt, D. F., Yost, H. J., & Virshup, D. M. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601607 · Cited by 132
Civenni, G., Holbro, T., & Hynes, N. E. (2003) · EMBO Reports · doi:10.1038/sj.embor.embor735 · Cited by 132
Search for a common mechanism of mood stabilizers
Harwood, A. J., & Agam, G. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00187-4 · Cited by 134
Bierie, B., Nozawa, M., Renou, J., Shillingford, J. M., Morgan, F., Oka, T., Taketo, M. M., Cardiff, R. D., Miyoshi, K., Wagner, K., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206426 · Cited by 132
The CRM1 nuclear export protein in normal development and disease.
Nguyen, K. T., Holloway, M. P., & Altura, R. A. (2012) · Europe PMC (PubMed Central) · Cited by 131
COX‐2 and cancer: a new approach to an old problem
Bakhle, Y. S. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704365 · Cited by 131
Wnt signaling and hepatocarcinogenesis: The hepatoblastoma model
Armengol, C., Cairo, S., Fabrè, M., & Buendia, M. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.07.012 · Cited by 137
Regulation of leukemic cell adhesion, proliferation, and survival by β-catenin
Chung, E. J., Hwang, S., Nguyen, P., Lee, S., Kim, J.-S., Kim, J. W., Henkart, P. A., Bottaro, D. P., Soon, L., Bonvini, P., et al. (2002) · Blood · doi:10.1182/blood.v100.3.982 · Cited by 131
Identification of a global gene expression signature of B-chronic lymphocytic leukemia.
Jelinek, D. F., Tschumper, R. C., Stolovitzky, G. A., Iturria, S. J., Tu, Y., Lepre, J., Shah, N. H., & Kay, N. E. (2003) · PubMed · Cited by 131
Spencer, T. E., Dunlap, K. A., & Filant, J. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.035 · Cited by 139
“…that are homologous to the Drosophila segment polarity gene wingless (wg) and regulate stem cell fate, cell differentiation and tissue growth (Polakis, 2000) through frizzled receptors (Fzd) (Pandur et al., 2002) via canonical and noncanonical signaling pathways (Angers and Moon, 2009).”
BackgroundWnt/β-Catenin activation promotes prostate tumor progression in a mouse model
Yu, X., Wang, Y., DeGraff, D. J., Wills, M. L., & Matusik, R. J. (2010) · Oncogene · doi:10.1038/onc.2010.560 · Cited by 130
Targeted inactivation of CTNNB1 reveals unexpected effects of β-catenin mutation
Chan, T. A.-T., Wang, Z., Dang, L. H., Vogelstein, B., & Kinzler, K. W. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082240999 · Cited by 130
Schlosshauer, P. W., Ellenson, L. H., & Soslow, R. A. (2002) · Modern Pathology · doi:10.1097/01.mp.0000028573.34289.04 · Cited by 130
Fu, J., Tang, W., Du, P., Wang, G., Chen, W., Li, J., Zhu, Y., Gao, J., & Cui, L. (2012) · BMC Systems Biology · doi:10.1186/1752-0509-6-68 · Cited by 133
“In this study, only the Wnt signaling pathway, which had been proved to be aberrantly activated in CRC [45,46], was found to be affected”
Chromosome 8q24-Associated Cancers and MYC
Grisanzio, C., & Freedman, M. L. (2010) · Genes & Cancer · doi:10.1177/1947601910381380 · Cited by 130
Leung, K. W., Pon, Y. L., Wong, R. N., & Wong, A. S. T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606698200 · Cited by 129
Miller, S. J., Lavker, R. M., & Sun, T. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.07.003 · Cited by 129
Johnson, M. L., & Rajamannan, N. M. (2006) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-006-9003-3 · Cited by 134
Leow, C. C., Romero, M. S., Ross, S., Polakis, P. G., & Gao, W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0290 · Cited by 129
Crosstalk between NF-κB and β-catenin pathways in bacterial-colonized intestinal epithelial cells
Sun, J., Hobert, M. E., Duan, Y., Rao, A. S., He, T., Chang, E. B., & Madara, J. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00515.2004 · Cited by 129
Magrangeas, F., Nasser, V., Avet‐Loiseau, H., Loriod, B., Decaux, O., Granjeaud, S., Bertucci, F., Birnbaum, D., Nguyen, C., Harousseau, J., et al. (2003) · Blood · doi:10.1182/blood-2002-11-3385 · Cited by 129
Vijayakumar, S., Liu, G., Rus, I. A., Yao, S., Chen, Y., Akiri, G., Grumolato, L., & Aaronson, S. A. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.010 · Cited by 128
Ye, H., Li, L., Guo, H., & Yin, Y. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205232109 · Cited by 128
“In the WNT signaling pathway, GSK3 kinase phosphorylates positive regulator β-catenin in a protein complex including scaffolding protein Axin, leading to β-catenin degradation (59).”
BackgroundGenetically encoded calcium indicator illuminates calcium dynamics in primary cilia
Su, S. H., Phua, S. C., DeRose, R., Chiba, S., Narita, K., Kalugin, P. N., Katada, T., Kontani, K., Takeda, S., & Inoue, T. (2013) · Nature Methods · doi:10.1038/nmeth.2647 · Cited by 132
Fritzmann, J., Morkel, M., Besser, D., Budczies, J., Kosel, F., Brembeck, F. H., Stein, U., Fichtner, I., Schlag, P. M., & Birchmeier, W. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.03.041 · Cited by 128
Wnt Signalling Pathway Parameters for Mammalian Cells
Tan, C. W., Gardiner, B. S., Hirokawa, Y., Layton, M. J., Smith, D. W., & Burgess, A. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031882 · Cited by 127
The inhibitory mechanism of curcumin and its derivative against β‐catenin/Tcf signaling
Park, C. H., Hahm, E., Park, S., Kim, H.-K., & Yang, C. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.04.013 · Cited by 131
Signal transduction during amyloid-β-peptide neurotoxicity: role in Alzheimer disease
Fuentealba, R. A., Farı́as, G. G., Scheu, J., Bronfman, M., Marzolo, M., & Inestrosa, N. C. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.07.018 · Cited by 126
Suksaweang, S., Lin, C., Jiang, T., Hughes, M. W., Widelitz, R. B., & Chuong, C. (2003) · Developmental Biology · doi:10.1016/j.ydbio.2003.10.010 · Cited by 127
Wnt signaling during development of the gastrointestinal tract
Theodosiou, N. A., & Tabin, C. J. (2003) · Developmental Biology · doi:10.1016/s0012-1606(03)00185-4 · Cited by 127
Structure and Function of Latency-Associated Nuclear Antigen
Verma, S. C., Lan, K., & Robertson, E. S. (2006) · Springer eBooks · doi:10.1007/978-3-540-34344-8_4 · Cited by 128
Thudi, N. K., Martin, C. K., Murahari, S., Shu, S. T., Lanigan, L. G., Werbeck, J. L., Keller, E. T., McCauley, L. K., Pinzone, J. J., & Rosol, T. J. (2010) · The Prostate · doi:10.1002/pros.21277 · Cited by 126
Traf2- and Nck-Interacting Kinase Is Essential for Wnt Signaling and Colorectal Cancer Growth
Shitashige, M., Satow, R., Jigami, T., Aoki, K., Honda, K., Shibata, T., Ono, M., Hirohashi, S., & Yamada, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0306 · Cited by 129
Plateroti, M., Kress, E., Mori, J. I., & Samarut, J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.3204-3214.2006 · Cited by 133
Edlund, S., Lee, S. Y., Grimsby, S., Zhang, S., Aspenström, P., Heldin, C., & Landström, M. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.4.1475-1488.2005 · Cited by 125
Maher, M. T., Flozak, A. S., Stocker, A. M., Chenn, A., & Gottardi, C. J. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200811108 · Cited by 123
Yu, X., Shi, W., Zhang, Y., Wang, X., Sun, S., Song, Z., Liu, M., Zeng, Q., Cui, S., & Qu, X. (2017) · Scientific Reports · doi:10.1038/srep42226 · Cited by 124
Schweizer, L., & VARMUS, H. E. (2003) · BMC Cell Biology · doi:10.1186/1471-2121-4-4 · Cited by 125
Dashwood, W., Orner, G. A., & Dashwood, R. H. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00914-2 · Cited by 125
Hahn, J., Cho, H.-J., Bae, J.-W., Yuk, H.-S., Kim, K., Park, K. W., Koo, B.-K., Chae, I., Shin, C.-S., Oh, B., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603916200 · Cited by 124
3′-End Sequencing for Expression Quantification (3SEQ) from Archival Tumor Samples
Beck, A. H., Weng, Z., Witten, D., Zhu, S., Foley, J. W., Lacroute, P., Smith, C. L., Tibshirani, R. J., van de Rijn, M., Sidow, A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008768 · Cited by 126
Austinat, M., Dunsch, R., Wittekind, C., Tannapfel, A., Gebhardt, R., & Gaunitz, F. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-21 · Cited by 128
miR-600 inhibits lung cancer via downregulating the expression of METTL3
Wei, W., Huo, B., & Shi, X. (2019) · Cancer Management and Research · doi:10.2147/cmar.s181058 · Cited by 124
“Wnt proteins also control kinase-signaling pathways.(24,25) Notably, canonical Wnt3a increases PI3K/Akt activity and increased free β-catenin levels.”
BackgroundChen, B., Jiang, W., Huang, Y., Zhang, J., Yu, P., Wu, L., & Peng, H. (2022) · Oncogene · doi:10.1038/s41388-022-02250-9 · Cited by 123
An, F., Compitello, N., Horwitz, E., Sramkoski, M., Knudsen, E., & Renne, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m407435200 · Cited by 140
Sääf, A. M., Halbleib, J. M., Chen, X., Yuen, S. T., Leung, S. Y., Nelson, W. J., & Brown, P. O. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-04-0309 · Cited by 125
Houghton, O. P., Connolly, L. E., & McCluggage, W. G. (2008) · Histopathology · doi:10.1111/j.1365-2559.2008.03083.x · Cited by 123
Wahab, N. A. A., Lajis, N. H., Abas, F., Othman, I., & Naidu, R. (2020) · Nutrients · doi:10.3390/nu12030679 · Cited by 127
Hsu, W., Shakya, R., & Costantini, F. (2001) · Journal of Cell Biology · doi:10.1083/jcb.200107066 · Cited by 137
Flozak, A. S., Lam, A. P., Russell, S., Jain, M., Peled, O. N., Sheppard, K. A., Beri, R., Mutlu, G. M., Budinger, G. R. S., & Gottardi, C. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.070326 · Cited by 123
Johnson, V., Volikos, E., Halford, S. E., Sadat, E. T. E., Popat, S., Talbot, I., Truninger, K., Martin, J., Jass, J. R., Houlston, R. S., et al. (2005) · Gut · doi:10.1136/gut.2004.048132 · Cited by 123
Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells.
Gao, Z., Xu, Z., Hung, M., Lin, Y., Wang, T., Gong, M., Zhi, X., Jablon, D. M., & You, L. (2009) · PubMed · Cited by 123
Zilberberg, A., Yaniv, A., & Gazit, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311292200 · Cited by 124
Mouse Axin and Axin2/Conductin Proteins Are Functionally Equivalent In Vivo
Chia, I. V., & Costantini, F. D. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.11.4371-4376.2005 · Cited by 121
PTEN in Autism and Neurodevelopmental Disorders.Preprint
Rademacher, S., & Eickholt, B. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036780 · Cited by 106
“The cross talk between PI3K and β-catenin signaling is important in this decision as AKT directly phosphorylates β-catenin and inhibits GSK3β-induced β-catenin destruction (Polakis 2000; Fang et al. 2007).”
BackgroundActivation of Wnt/β-catenin/Tcf signaling pathway in human astrocytomas
Sareddy, G. R., Panigrahi, M. K., Challa, S., Mahadevan, A., & Babu, P. P. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.03.016 · Cited by 121
Rampias, T., Boutati, E. I., Pectasides, E., Sasaki, C. T., Kountourakis, P., Weinberger, P., & Psyrri, A. K. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0345 · Cited by 128
Marra, N. J., Stanhope, M. J., Jue, N. K., Wang, M., Sun, Q., Bitar, P. P., Richards, V. P., Komissarov, A. S., Rayko, M., Kliver, S. F., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1819778116 · Cited by 123
“The Wnt signaling pathway increases quantities of β-catenin, which in turn can initiate transcriptional activation of proteins controlling the G1 to S phase cell cycle transition, ultimately leading to cell proliferation (34).”
BackgroundHindgut defects and transformation of the gastro‐intestinal tract in Tcf4−/−/Tcf1−/− embryos
Gregorieff, A., Grosschedl, R., & Clevers, H. C. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600191 · Cited by 123
Thorstensen, L., Lind, G. E., Løvig, T., Diep, C. B., Meling, G. I., Rognum, T. O., & Lothe, R. A. (2005) · Neoplasia · doi:10.1593/neo.04448 · Cited by 122
Novel genes regulated by Sonic Hedgehog in pluripotent mesenchymal cells
Ingram, W. J., Wicking, C., Grimmond, S. M., Forrest, A. R. R., & Wainwright, B. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205975 · Cited by 122
Deng, Y.-Z., Chen, P.-P., Wang, Y., Yin, D., Koeffler, H. P., Li, B., Tong, X.-J., & Xie, D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704141200 · Cited by 122
Tran, H., Hamada, F., Schwarz, T., & Bienz, M. (2008) · Genes & Development · doi:10.1101/gad.463208 · Cited by 122
Inhibition of Fibroblast Growth Factor 19 Reduces Tumor Growth by Modulating β-Catenin Signaling
Pai, R., Dunlap, D. Y., Qing, J., Mohtashemi, I., Hötzel, K., & French, D. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2325 · Cited by 124
APC dosage effects in tumorigenesis and stem cell differentiation
Gaspar, C., & Fodde, R. (2004) · The International Journal of Developmental Biology · doi:10.1387/ijdb.041807cg · Cited by 123
Gaujoux, S., Pinson, S., Gimenez‐Roqueplo, A., Amar, L., Ragazzon, B., Launay, P., Méatchi, T., Libé, R., BERTAGNA, X. Y., Audebourg, A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1497 · Cited by 121
The Crystal Structure of the β-Catenin/ICAT Complex Reveals the Inhibitory Mechanism of ICAT
Graham, T. A., Clements, W. K., Kimelman, D., & Xu, W. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00637-8 · Cited by 124
Deletion of a Single β-Catenin Allele in Osteocytes Abolishes the Bone Anabolic Response to Loading
Javaheri, B., Stern, A. R., Lara, N., Dallas, M., Zhao, H. L., Liu, Y., Bonewald, L. F., & Johnson, M. L. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2064 · Cited by 124
Frequent epigenetic inactivation of SFRP genes in hepatocellular carcinoma
Takagi, H., Sasaki, S., Suzuki, H., Toyota, M., Maruyama, R., Nojima, M., Yamamoto, H., Omata, M., Tokino, T., Imai, K., et al. (2008) · Journal of Gastroenterology · doi:10.1007/s00535-008-2170-0 · Cited by 119
Unfolding the Role of Large Heat Shock Proteins: New Insights and Therapeutic Implications
Zuo, D., Subjeck, J. R., & Wang, X. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00075 · Cited by 122
“Given that the majority of colon cancer patients have APC mutations and active Wnt/β-catenin signaling, these findings establish Hsp110 as a prognostic biomarker and as a potential therapeutic target for the treatment of colon cancer (100, 101).”
BackgroundDehner, M., Hadjihannas, M. V., Weiske, J., Huber, O., & Behrens, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710366200 · Cited by 116
Xiang, D., Wang, D., He, Y., Xie, J., Zhong, Z., Li, Z., & Xie, J. (2006) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000224441.01082.bb · Cited by 119
Mouse models for colorectal cancer
Heyer, J., Yang, K., Lipkin, M., Edelmann, W., & Kucherlapati, R. (1999) · Oncogene · doi:10.1038/sj.onc.1203036 · Cited by 120
Dang, D. T., Mahatan, C. S., Dang, L. H., Agboola, I. A., & Yang, V. W. (2001) · Oncogene · doi:10.1038/sj.onc.1204645 · Cited by 120
Kroboth, K., Newton, I. P., Kita, K., Dikovskaya, D., Zumbrunn, J., Waterman, C. M., & Näthke, I. S. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-03-0179 · Cited by 119
Regulation of the G1 to S transition by the ubiquitin pathway
DeSalle, L. M., & Pagano, M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02121-4 · Cited by 119
Kumagai, T., O’Kelly, J., SAID, J. W., & Koeffler, H. P. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.12.896 · Cited by 121
Gleason, J. E., Korswagen, H. C., & Eisenmann, D. M. (2002) · Genes & Development · doi:10.1101/gad.981602 · Cited by 119
Ovejero, C., Cavard, C., Périanin, A., Hakvoort, T., Vermeulen, J., Godard, C., Fabre, M., Chafey, P., Suzuki, K., Romagnolo, B., et al. (2004) · Hepatology · doi:10.1002/hep.20286 · Cited by 118
Kwon, Y., Baek, H., Ye, D.-J., Shin, S., Kim, D., & Chun, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151598 · Cited by 118
“Following activation by Wnt ligand-receptor binding, β-catenin escapes proteosomal degradation and translocates into the nucleus, where it binds its target genes and promotes multiple pathways involved in carcinogenesis [20, 21].”
BackgroundInfluentialKim, S., Choi, H.-I., Ryu, H., Park, J. H., Kim, M. D., & Kim, S. Y. (2004) · PLANT PHYSIOLOGY · doi:10.1104/pp.104.049189 · Cited by 116
Chan, A. O. O. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i2.199 · Cited by 118
Binding of APC and dishevelled mediates Wnt5a‐regulated focal adhesion dynamics in migrating cells
Matsumoto, S., Fumoto, K., Okamoto, T., Kaibuchi, K., & Kikuchi, A. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.26 · Cited by 120
Wang, K., Wang, X., Zou, J., Zhang, A., Wan, Y., Pu, P., Song, Z., Qian, C., Chen, Y., Yang, S., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not004 · Cited by 117
“The Wnt signaling pathway regulates many biological processes through a complex of beta-catenin and the T cell factor/lymphoid-enhancer factor 1 (TCF/LEF-1) family of high-mobility group transcription factors.(3,4) Wnt stabilizes cytosolic betacatenin, which then binds to TCF/LEF-1 and recruits transcription factors B…”
BackgroundVitamin D and Colon Carcinogenesis
Harris, D. M., & Go, V. L. W. (2004) · Journal of Nutrition · doi:10.1093/jn/134.12.3463s · Cited by 116
Winn, R. A., Scoyk, M. M. V., Hammond, M., Rodriguez, K. J., Crossno, J. T., Heasley, L. E., & Nemenoff, R. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604145200 · Cited by 115
Kita, K., Wittmann, T., Näthke, I. S., & Waterman, C. M. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-06-0498 · Cited by 117
Revisiting the role of Wnt/β-catenin signaling in prostate cancer
Schneider, J. A., & Logan, S. K. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.02.008 · Cited by 115
“Introduction β-catenin is an effector of the Wnt family of proteins, an evolutionarily conserved group of signaling molecules that regulate developmental and biological processes (Miller et al., 1999; Polakis, 2000; Wodarz and Nusse, 1998).”
BackgroundThe β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway
Chen, H., Hsu, L.-S., Shia, Y.-T., Lin, M., & Lin, C.-M. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.08.011 · Cited by 120
Identification of a Role for β-Catenin in the Establishment of a Bipolar Mitotic Spindle
Kaplan, D. D., Meigs, T. E., Kelly, P., & Casey, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400035200 · Cited by 116
Feng, Y., Lee, N., & Fearon, E. R. (2003) · PubMed · Cited by 116
Wnt signalling and cancer stem cells
Espada, J., Blanco, M., Díaz‐Prado, S., & Médina, V. (2009) · Clinical & Translational Oncology · doi:10.1007/s12094-009-0380-4 · Cited by 116
Metadata
- Authors
- Polakis, P.
- Affiliations
- Genentech (US)
- Corresponding author
- Polakis, Paul
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2000-08-01
- Volume
- 14
- Issue
- 15
- Pages
- 1837-1851
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2239090104
- Cited by
- 3,183
- References
- 190
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 25 · 2023: 43 · 2022: 39 · 2021: 46 · 2020: 56 · 2019: 67 · 2018: 71 · 2017: 86 · 2016: 110 · 2015: 144 · 2014: 138 · 2013: 147 · 2012: 174
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
- Keywords
- Wnt signaling, β-catenin, cancer, oncogenic transformation, transcriptional activation, gene expression profiles, experimental tumor model
- MeSH terms
- Dishevelled Proteins, Animals, Cytoskeletal Proteins, Humans, Neoplasms, Phosphoprotein Phosphatases, Phosphoproteins, Proto-Oncogene Proteins, Transcription Factors, Signal Transduction, Trans-Activators, Calcium-Calmodulin-Dependent Protein Kinases, Adenomatous Polyposis Coli Protein, Zebrafish Proteins, Glycogen Synthase Kinase 3, Adaptor Proteins, Signal Transducing, Wnt Proteins, beta Catenin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review